Alkali Metal Or Alkaline Earth Metal Patents (Class 424/665)
  • Patent number: 9945584
    Abstract: The present invention provides an excellent heating tool in which the generation of unpleasant odors is suppressed. The present invention also provides an excellent heating tool in which changes in aroma are suppressed. The present invention further provides an excellent heating tool in which the generation of unpleasant odors and changes in aroma are suppressed even after storage. The present invention provides a method for suppressing the generation of unpleasant odors and changes in aroma in a heating tool. The present invention provides a heating tool comprising an exothermic composition containing a metal ion sequestrant, an oxidizable metal powder, a water-soluble salt, and water, wherein at least the exothermic composition is housed in an air-permeable container bag.
    Type: Grant
    Filed: July 29, 2013
    Date of Patent: April 17, 2018
    Assignee: Kobayashi Pharmaceutical Co., Ltd.
    Inventors: Yuki Yasuda, Hiromichi Tanaka, Daisuke Nishioka
  • Patent number: 9204633
    Abstract: A water based, alcohol-free, skin sanitizing solution with a natural skin softener, where the nature of the biocidal enhancer used in the process of making the solution significantly increases efficacy while simultaneously enabling much more economical manufacturing, processing and transportation of the product. Because it is water based, no further moisturizing additives are required, and those with sensitive skin, diabetes, allergies or religious beliefs are able to use the product without concern.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: December 8, 2015
    Assignee: Aphex Biocleanse Systems, Inc.
    Inventor: David John Weaver
  • Publication number: 20150132409
    Abstract: Agents and devices for affecting nerve function are described. In some variations, a combination of agents, e.g., a cardiac glycoside, an ACE inhibitor, and an NSAID are delivered to affect nerve function. The agent may be delivered locally in a site-specific manner to a targeted nerve or portion of a nerve. For example, the agent may be delivered locally to the renal nerves to impair their function and treat hypertension. One variation of a delivery device includes one or more needle housings supported by a balloon. A delivery needle is slidably disposed within a needle lumen of each needle housing.
    Type: Application
    Filed: May 7, 2013
    Publication date: May 14, 2015
    Inventors: Emily A. Stein, Christina D. Swanson, Michael A. Evans, Kondapavulur T. Venkateswara-Rao
  • Publication number: 20150125551
    Abstract: A method of manufacturing and an apparatus for making an aqueous chlorine solution having a pH between 3.0 and 6.5 and a stability such that after 6 weeks storage at 20 degrees Celsius the pH remains in the range 3.0 to 6.5 and the amount of chlorine lost from the solution is less than 10%, such that the method includes: (a) Providing a source of water having an electrical conductivity at 20 degrees Celsius of no more than 50 (and preferably no more than 4.3) ?Scm-1 (b) Reacting the water with solid calcium hypochlorite having a purity of at least 60%; and (c) Adjusting the pH to between 3.0 and 6.5.
    Type: Application
    Filed: October 20, 2014
    Publication date: May 7, 2015
    Inventors: Stephen Thomas BOND, Kevin John BYRNE, Simon Joseph WARD, Natasha Ann Crawford PAGE
  • Publication number: 20150118325
    Abstract: The present invention provides a method for preventing or treating an inflammatory response, condition or disease in a mammal comprising administering an effective amount of a dilute stabilised hypochlorite solution to said mammal in need thereof as well as a means for mixing and administering fresh, dilute stabilised hypochlorite solution to the site where it is needed.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Applicant: Hypo-Stream Limited
    Inventor: Myles H. E. Dakin
  • Patent number: 9005671
    Abstract: This invention provides concentrated aqueous biocidal solutions formed from bromine chloride, sodium hydroxide, and sulfamic acid. The weight ratio of bromine chloride:sodium hydroxide:sulfamic acid used in forming the concentrated solution is such that for every 10.5 to 11.5 parts by weight of bromine chloride used, 15.3 to 17.5 parts by weight of sodium hydroxide and 11.0 to 12.5 parts by weight of sulfamic acid are used, the biocidal solution containing at least about 100,000 ppm (wt/wt) of active bromine based on the total weight of the solution.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: April 14, 2015
    Assignee: Albemarle Corporation
    Inventor: Farah D. Azarnia
  • Publication number: 20150056303
    Abstract: The present invention is directed to a method, system and equipment for the elaboration of electrolytic chlorine oxidants, hypochlorous acid and sodium hypochlorite substances, using elements that result in an ecological process and confers a high efficiency in the production of these substances, permitting the generation of a product of very high performance and efficiency.
    Type: Application
    Filed: August 23, 2013
    Publication date: February 26, 2015
    Inventors: Miguel Angel Alcantara, Adan Tapia Duran
  • Publication number: 20150044301
    Abstract: A system is disclosed for preparing a hypodermic injection site comprising a visibility enhancer for an injection site and a post injection hypodermic puncture wound site. The present invention offers a number of significant improvements which advance the efficacy of the art, by: preventing unintentional hypodermic injection of medicines through un-sanitized or under-sanitized skin surfaces, thereby protecting patients from becoming inoculated with pathogenic microorganisms while receiving such injections; significantly improving the visibility of, and, the accurate visual location and bandaging of post-injection needle puncture entry wounds, thereby further reducing the risk of infection of such wounds; and, by reducing bleeding from such wounds, which, in turn, reduces healthcare worker exposure to blood-borne pathogens and reduces the generation of potentially infectious, biohazardous medical waste.
    Type: Application
    Filed: August 8, 2013
    Publication date: February 12, 2015
    Inventor: Hans Werner Bottesch
  • Publication number: 20150037320
    Abstract: The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.
    Type: Application
    Filed: May 6, 2014
    Publication date: February 5, 2015
    Applicants: Neuraltus Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: Michael S. McGrath, Arasteh Ari Azhir
  • Patent number: 8940340
    Abstract: Systems and methods for maintaining the dominance of Nannochloropsis in an algae cultivation system are provided. Exemplary methods include applying an effective amount of a disinfectant to Nannochloropsis growing in an algae cultivation system. Another method for maintaining the dominance of Nannochloropsis in an algae cultivation system includes adjusting a salinity in the algae cultivation system to between approximately 0.5 PPT and 28 PPT. In a further method, the temperature of the algae cultivation system may be adjusted to between approximately 21 and 32 degrees Celsius (“° C.”). According to yet another method for maintaining the dominance of Nannochloropsis in an algae cultivation system, a salinity in the algae cultivation system may be adjusted to below that of seawater for a first predetermined period of time, and then the salinity in the algae cultivation system may be adjusted to a higher salinity for a second predetermined period of time.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: January 27, 2015
    Assignee: Aurora Algae, Inc.
    Inventors: Joseph Weissman, Guido Radaelli
  • Publication number: 20150004254
    Abstract: An externally-used solution containing chlorine dioxide for promoting hair growth is composed of chlorine dioxide or its precursors, pH regulators, medical solvents and plant extract in a certain weight ratio. The product may take the forms of a single solution containing chlorine dioxide or several solutions containing a chlorine dioxide precursor. The safety and effective oxidation sterilization and tissue regeneration ability of chlorine dioxide are introduced into the solution system for promoting hair growth, and the steps of removing hair loss factors, stimulating the growth of hair follicles, anti-inflammatory and anti-dandruff are done synchronously. Complemented medical solvents and plant extracts will change alopecia environment.
    Type: Application
    Filed: September 1, 2012
    Publication date: January 1, 2015
    Inventor: Xuewu Liu
  • Publication number: 20150001066
    Abstract: A wipe for anti-microbial disinfecting includes a flexible substrate and an anti-microbial ion source integrated on the substrate. The flexible substrate is made entirely or in part of woven fiber cloth, non-woven fiber cloth, woven synthetic cloth, non-woven synthetic cloth, or natural fiber cloth. The anti-microbial ion source is configured to dissolve in an aqueous solution to form an anti-microbial solution. The flexible substrate is configured to absorb the anti-microbial solution for use in cleaning.
    Type: Application
    Filed: June 25, 2014
    Publication date: January 1, 2015
    Inventor: Ashok V. Joshi
  • Publication number: 20140348951
    Abstract: A dialysis acid precursor assembly including: a dry dialysis acid precursor composition including sodium chloride, a dry acid and a magnesium chloride 4.5-hydrate (MgCl2.4.5H2O), a calcium salt and at least one of a potassium salt, calcium salt and an anhydrous glucose, and a moisture-resistant container having a water vapor transmission rate less than 0.2 g/m2/d at 38° C./90% RH, wherein the dry dialysis acid precursor composition is sealed in the container.
    Type: Application
    Filed: December 11, 2012
    Publication date: November 27, 2014
    Inventors: Olof Jansson, Jens Gustafsson, Torbjorn Linden
  • Publication number: 20140319059
    Abstract: Provided herein is a method for reducing down-time in a recreational body of water having a water filtering system and water recirculation system after a potential release of Cryptospridium oocyst and/or Giardia cysts. Also described is a kit for practicing the method for reducing down-time in a recreational body of water that may have a potential release of Cryptospridium oocyst and/or Giardia cysts.
    Type: Application
    Filed: April 25, 2014
    Publication date: October 30, 2014
    Inventor: Michael Joseph Unhoch
  • Patent number: 8871278
    Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solution, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing surfaces, or treating and/or preserving food products and cut flowers, among other uses.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: October 28, 2014
    Assignee: Puricore, Inc.
    Inventors: Svetlana Panicheva, Mark N. Sampson, Vadim Panichev, Gerald N. Dibello, Martyn James Rogers, Ronan Stapleton, Steven Lewis Short
  • Publication number: 20140302107
    Abstract: The invention provides an aqueous bleaching solution for substrate treatment. The aqueous bleaching solution features a source of oxidant and a plurality of optically functional nanoparticles. The optically functional nanoparticles are nanoparticles in the range of about 0.1 nanometers to about 400 nanometers in size. The aqueous bleaching solution may optionally include one or more an oxidant-stable surfactants and optionally, one or more oxidant-stable polymers, and adjuncts. The optically functional nanoparticles are extremely stable in the aqueous bleaching solution and remain substantially suspended in the aqueous bleaching solution due to their extremely small size despite having an average density greater than that of the bleaching solution.
    Type: Application
    Filed: December 13, 2013
    Publication date: October 9, 2014
    Applicant: The Clorox Company
    Inventors: Gregory VanBuskirk, Scott L. Cumberland, Thomas W. Kaaret, William L. Smith
  • Publication number: 20140287065
    Abstract: Pigs infected with PEDv often die due to dehydration caused by diarrhea. Those that survive do not reach market weight as scheduled resulting in costs to the producer. The invention includes providing electrolyzed water either as treatment for infected animals or as a prophylactic against symptom severity in uninfected animals. The electrolyzed water is used as a substitute for or as a solution with regular drinking water. Duration of symptoms for infected pigs is markedly lessened; severity of symptoms is also reduced providing a much higher survival rate. Time to market is less negatively affected for surviving pigs than those untreated, and weight at scheduled time for sale is also less effected translating into positive financial results over those expected for untreated herds.
    Type: Application
    Filed: February 24, 2014
    Publication date: September 25, 2014
    Applicant: Ag Odor Control, LLC
    Inventor: Robert D. Watson
  • Publication number: 20140287064
    Abstract: Fungal infections and other disease conditions of the integument can be effectively treated with compositions containing ozonizable oils, plant extract oils and antimicrobials, when used in conjunction with solutions containing sodium chlorite. The compositions are particularly useful for treatment of resistant fungal infections.
    Type: Application
    Filed: May 28, 2014
    Publication date: September 25, 2014
    Inventor: Karen G. Swenholt
  • Publication number: 20140212512
    Abstract: The invention provides a liquid composition when used for maintenance of a body of water, the liquid composition comprising a solution of magnesium and potassium salts, at least one of which is a halide salt. Preferably, the liquid composition comprises Mg2+ from the magnesium salt in an amount of from about 6000 ppm to about 15 000 ppm; K+ from the potassium salt in an amount from about 40 000 ppm to about 120 000 ppm and hypohalite from the halide in an amount from about 100 000 ppm to about 400 000 ppm.
    Type: Application
    Filed: July 10, 2012
    Publication date: July 31, 2014
    Applicant: Zodiac Group Australia Pty Ltd
    Inventor: Ross Leslie Palmer
  • Publication number: 20140178501
    Abstract: A method for controlling microbial or biofilm growth in a medium includes mixing ammonium carbamate or ammonium sulfamate with an aqueous solution of a hypochlorite oxidant to form a biocide having a pH between 9.0 and 11.5, the molar ratio of the ammonium carbamate or ammonium sulfamate to the hypochlorite being at least 1:1; and then applying the biocide to the medium.
    Type: Application
    Filed: December 11, 2013
    Publication date: June 26, 2014
    Inventor: Ayala BARAK
  • Publication number: 20140134278
    Abstract: The present invention provides a composition containing an aluminate and calcium hypochlorite, wherein the content of the aluminate is 1.0 part by weight to less than 2 parts by weight based on 100 parts by weight of the composition.
    Type: Application
    Filed: June 21, 2012
    Publication date: May 15, 2014
    Inventors: Toshiyuki Yamashita, Yoshinori Kamatsuchi
  • Patent number: 8709498
    Abstract: A method of stimulating tissue healing in humans or animals includes administering to a human or animal suffering from lesions and infections linked to chronic and/or acute periodontitis a pharmaceutically effective amount of a pharmaceutical composition including (i) at least one sodium halopohalite, and (ii) at least one N-halogenated taurine, wherein halogens from the (i) at least one sodium halopohalite and from the (ii) at least one N-haloamine taurine, which may be the same or different, are selected from the group consisting of fluorine, iodine, bromine and chlorine.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: April 29, 2014
    Inventor: Arnaud Mainnemare
  • Publication number: 20140113007
    Abstract: Provided is a chlorine dioxide-generating product comprising an inorganic porous carrier carrying a chlorite and an alkali agent. In the product, the alkali agent is carried in an amount of more than 0.7 molar equivalent and not more than 2 molar equivalents relative to the amount of the chlorite carried, and the product has a water content of 10% by weight or less. The chlorine dioxide-generating product can stably generate chlorine dioxide gas in an amount that sufficiently achieves deodorization, sterilization, virus removal, mold prevention, antisepsis, or the like of spatial environments, foods, or others but exerts no harmful effect on humans, over a long period of time.
    Type: Application
    Filed: May 30, 2012
    Publication date: April 24, 2014
    Applicant: DAISO CO., LTD.
    Inventors: Ryo Kato, Kanefusa Hara, Masanori Yanagida
  • Patent number: 8691285
    Abstract: Methods of using a non-irritant, low pH acidic composition to destroy undesirable microorganisms are described. The methods may be used on food products, food processing equipment, and in aqueous solutions.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: April 8, 2014
    Assignee: CMS Innovative Technologies, Inc.
    Inventors: Barry Cummins, David Creasey
  • Patent number: 8691286
    Abstract: A composition for dissolving or reducing the viscosity of sputum on a surface of a device includes an effective amount of glycerol and an effective amount of dextran sulfate in a saline solution. The effective amount of glycerol is between about 30-50% and the effective amount of dextran sulfate is between about 10-30%. The composition may further include an antimicrobial agent.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: April 8, 2014
    Assignee: Teleflex Medical Incorporated
    Inventors: Nisha Gupta, Erin Peters, Joel Rosenblatt
  • Patent number: 8679548
    Abstract: Described are highly concentrated liquid biocidal solutions formed in water from (a) specified bromine sources (e.g., BrCl or mixtures of BrCl and Br2) and (b) alkali metal salt of sulfamic acid and/or sulfamic acid and alkali metal base, wherein the solution contains >160,000 ppm of active bromine. Solutions of this type have been found to have greater stability than a commercially-available solution made from the same components containing 148,600 ppm of active bromine. Also described are new, water-soluble, solid state biocidal products formed by removing the water from solutions made in water from (a) and (b) irrespective of the initial concentration of active bromine. Removal of water can be accomplished by flashing or distillation at reduced pressure or preferably by spray drying. Such solid state products are typically in the form of powders or small particles, but can be compacted into larger forms preferably with the aid of one or more suitable binding agents.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: March 25, 2014
    Assignee: Albemarle Corporation
    Inventors: Christopher J. Nalepa, Robert M. Moore, Jr.
  • Patent number: 8663705
    Abstract: An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: March 4, 2014
    Assignee: Reoxcyn Discoveries Group, Inc.
    Inventors: Verdis Norton, Gary L. Samuelson
  • Patent number: 8632823
    Abstract: Super-oxidized water based on hypochlorous acid, such as is obtained by the electrochemical treatment of a saline solution, may be used in the treatment of leg ulcers or other open wounds. Preferably, the pH of the super-oxidized water is in a range of 4 to 7, and the water has a redox potential of >950 mV. Medicaments based on the super-oxidized water may be in liquid or gel form. The super-oxidized water is able to control the microbial population within the wound and at the same time permit cell proliferation.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: January 21, 2014
    Assignee: Puricore, Inc.
    Inventor: Joe B. Selkon
  • Publication number: 20130316020
    Abstract: This application described a wound dressing comprising an absorbent material, an effective amount of chlorite and an amount of a base to provide a pH of the dressing material greater than or equal to about (10). Advantageously, the wound dressings of the present application provide a convenient source of chlorite that is stable and easy to use.
    Type: Application
    Filed: February 9, 2012
    Publication date: November 28, 2013
    Inventors: Servet Buyuktimkin, Nadir Buyuktimkin, Edward T. Kisak, Dominic King-Smith, John M. Newsam, Jagat Singh
  • Publication number: 20130295022
    Abstract: The present invention provides a highly tolerable, hydrating lanolin containing foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa of the nose, mouth, eye, ear, respiratory system, vagina or rectum. The foamable composition includes lanolin, a surface-active agent, about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent, water, and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
    Type: Application
    Filed: June 6, 2013
    Publication date: November 7, 2013
    Inventors: Doron Friedman, Alex Besonov, Dov Tamarkin, Meir Eini
  • Patent number: 8568759
    Abstract: The present invention provides an environmentally compatible, pesticidal composition and method for the control of insect pests. The composition includes two components. The first component is a chelating agent, a metal complex of a chelating agent, and mixtures thereof, and the second component is preferably a carrier material.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: October 29, 2013
    Assignee: W. Neudorff GmbH KG
    Inventor: Diana L. Parker
  • Patent number: 8563019
    Abstract: Disclosed is a method of making a non-aqueous chlorine dioxide solution by combining a chlorite salt and a non-aqueous carboxylic acid and the non-aqueous chlorine dioxide solution made by this method. Also disclosed are methods of disinfecting an object by applying the non-aqueous chlorine dioxide solution to the object and methods of disinfecting a liquid by adding the non-aqueous chlorine dioxide solution to the liquid.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: October 22, 2013
    Assignee: Diversey, Inc.
    Inventor: Michael F. Coughlin
  • Patent number: 8541034
    Abstract: New electrical producing creams are provided. In one embodiment, the electrical producing creams comprise menthol and camphor, preferably provided as part of a base gel, supplemented with potassium and a source of oxygen. The most preferred base gel is sold under the name SOMBRA. In another embodiment, the electrical producing creams comprise potassium and a source of oxygen supplemented with optional active and inactive ingredients. The most preferred source of oxygen is a chlorite (e.g., sodium chlorite) and/or spirulina. The electrical producing creams provide high metabolic activities and sustain those activities over prolonged periods of time, thus being useful for treating a large variety of ailments, including diabetic neuropathy, post hepatic neuralgia, scleroderma, psoriasis, strain, spasticity, headaches, neuropathy secondary to drugs, peripheral neuropathy, leg pain, muscle cramps, muscle aches and pains, bruise, sinusitis, sprain, arthritis, joint pain (arthralgia), and edema.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: September 24, 2013
    Inventor: Clyde E. Morgan
  • Patent number: 8507011
    Abstract: A composition and method are described for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition. Fibrous adhesions typically form during healing of tissue, for example following a surgical procedure. A multicomponent oxychlorine composition is provided for irrigating the tissue which minimizes post-surgical adhesion formation, the composition containing both chlorine dioxide and chlorite ion, and a complexion thereof. The chlorine dioxide level generally is in an effective range of ClO2 concentration from about 10 ppm to a maximum of about 110 ppm. In a preferred embodiment, a physiological composition is provided in a thickened form to increase retention in the area being treated.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: August 13, 2013
    Inventors: Robert D. Kross, Cleva Villanueva
  • Patent number: 8501244
    Abstract: Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: August 6, 2013
    Assignee: Neuraltus Pharmaceuticals, Inc.
    Inventors: William Boulanger, Arasteh Ari Azhir
  • Patent number: 8455010
    Abstract: A balanced redox-signaling compound with reactive molecules that mimic those naturally occurring inside cells that have been precisely stabilized and formulated as a supplement for oral consumption acting to enhance proper immune system function, enhance the efficiency and production of the body's native antioxidants as well as enhance the performance of intercellular communications involved in healthy tissue maintenance and athletic performance.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: June 4, 2013
    Assignee: Reoxcyn Discoveries Group, Inc
    Inventors: Verdis Norton, Gary L. Samuelson
  • Patent number: 8449899
    Abstract: Disclosed is a method of making a non-aqueous chlorine dioxide solution by combining a chlorite salt and a non-aqueous carboxylic acid and the non-aqueous chlorine dioxide solution made by this method. Also disclosed are methods of disinfecting an object by applying the non-aqueous chlorine dioxide solution to the object and methods of disinfecting a liquid by adding the non-aqueous chlorine dioxide solution to the liquid.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: May 28, 2013
    Assignee: Diversey, Inc.
    Inventor: Michael F. Coughlin
  • Publication number: 20130101682
    Abstract: A composition and methods of its use, the composition comprising: a halogen source, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition is disclosed. Additionally, a method for reducing biological activity in a process stream is disclosed. The method comprises: providing a composition to a process stream, wherein said composition contains: a halogen, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition. The invention is also directed to compositions and methods of their use as effective biocidal agents for water streams.
    Type: Application
    Filed: November 4, 2011
    Publication date: April 25, 2013
    Applicant: NALCO COMPANY
    Inventors: Laura E. RICE, Andrew J. COOPER, Elisa M. LUTH, Wen Li TU
  • Publication number: 20130101683
    Abstract: The invention is directed to compositions and methods of their use as effective biocidal agents for water streams. The composition comprises a halogen source, halogen stabilizers containing a sulfur bearing species and ammonium salts/urea, and an alkali. The sulfur bearing species includes sulfamic acid or its salt equivalent. By having optimized mixing ratio of halogen to stabilizer and that of ammonium salts to sulfamic acid or sulfamate, a synergistic effect occurs which both increases the efficacy of the composition as a biocide and it avoids adverse impacts on other chemicals that are present in the water stream. Best of all the composition is easy to form and easy to introduce into a water stream of concern. Its introduction can be as simple as mixing two containers of reagent prior to introduction to the water process stream.
    Type: Application
    Filed: November 4, 2011
    Publication date: April 25, 2013
    Applicant: NALCO COMPANY
    Inventors: Wen Li TU, Laura E. RICE, Andrew J. COOPER, Elisa M. LUTH, Yu-mei LU, Jian Kun SHEN
  • Patent number: 8414932
    Abstract: Described are highly concentrated liquid biocidal solutions formed in water from (a) specified bromine sources (e.g., BrCl or mixtures of BrCl and Br2) and (b) alkali metal salt of sulfamic acid and/or sulfamic acid and alkali metal base, wherein the solution contains >160,000 ppm of active bromine. Solutions of this type have been found to have greater stability than a commercially-available solution made from the same components containing 148,600 ppm of active bromine. Also described are new, water-soluble, solid state biocidal products formed by removing the water from solutions made in water from (a) and (b) irrespective of the initial concentration of active bromine. Removal of water can be accomplished by flashing or distillation at reduced pressure or preferably by spray drying. Such solid state products are typically in the form of powders or small particles, but can be compacted into larger forms preferably with the aid of one or more suitable binding agents.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: April 9, 2013
    Assignee: Albemarie Corporation
    Inventors: Christopher J. Nalepa, Robert M. Moore, Jr.
  • Publication number: 20130072867
    Abstract: A portable device for mixing a dilute disinfectant solution comprising a first reservoir comprising a predetermined amount of said disinfectant solution, a chamber which is connected to said first reservoir and which holds a predetermined amount of dilutant, and means for discharging said predetermined amount of said disinfectant solution from said first reservoir into said chamber to be mixed with said predetermined amount of dilutant in said chamber wherein said device provides the dilute disinfectant solution at a fixed dilution determined by the ratio of the predetermined amount of said disinfectant solution to the predetermined amount of dilutant.
    Type: Application
    Filed: April 13, 2011
    Publication date: March 21, 2013
    Applicant: Hypo-Stream Limited
    Inventor: Myles H. E. Dakin
  • Patent number: 8399506
    Abstract: The present invention relates to the use of combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and an oxidizing agent, for eradicating, eliminating or reducing aquatic organisms in ballast water or bilge water whereby 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and the oxidizing agent are in respective proportions to provide a synergistic effect against fouling organisms. Suitable oxidizing agents are e.g.
    Type: Grant
    Filed: August 6, 2007
    Date of Patent: March 19, 2013
    Assignee: Janssen Pharmaceutica, NV
    Inventor: Tony Mathilde Jozef Kempen
  • Patent number: 8372348
    Abstract: An apparatus includes a reservoir for holding a chemical solution, a pump and a discharge nozzle. The pump has an inlet and an outlet connected to the reservoir by inlet and discharge lines. The nozzle is disposed in a lower portion of the reservoir and discharges the solution toward the bottom of the reservoir; the nozzle has an inlet port connected to the pump discharge line through the sidewall of the reservoir. The pump inlet line is connected to a sidewall of the reservoir at a location below a normal surface level of the solution, and the pump discharge line is connected to the sidewall of the reservoir above that location. The reservoir, pump, pump inlet line, pump discharge line, nozzle inlet line and nozzle form a closed loop recirculation system effective to suspend insoluble material in the chemical solution.
    Type: Grant
    Filed: June 23, 2009
    Date of Patent: February 12, 2013
    Assignee: Arch Chemicals, Inc.
    Inventors: Zachary Harris Adams, David W. Blanchette
  • Publication number: 20130034618
    Abstract: Fungal infections and other disease conditions of the integument can be effectively treated with compositions containing ozonizable oils and antimicrobials, when used in conjunction with solutions containing sodium chlorite. The compositions are particularly useful for treatment of resistant fungal infections.
    Type: Application
    Filed: August 3, 2012
    Publication date: February 7, 2013
    Inventor: Karen Swenholt
  • Patent number: 8367120
    Abstract: An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: February 5, 2013
    Assignee: Reoxcyn Discoveries Group, Inc.
    Inventors: Verdis Norton, Gary L. Samuelson
  • Publication number: 20130028990
    Abstract: The present invention provides a method of using a solid-layered composition having at least two parts. The first past comprises a) calcium hypochlorite, magnesium hypochlorite and mixtures thereof, b) a builder, c) a water-soluble polymer, d) an acid, and e) wherein the first part does not contain sodium hypochlorite, lithium hypochlorite, potassium hypochlorite and mixtures thereof. The second part comprises a) a surfactant b) a builder, c) an acid, and d) wherein the second part does not contain any oxidant.
    Type: Application
    Filed: September 11, 2012
    Publication date: January 31, 2013
    Inventors: William L. Smith, Evan M. Rumberger
  • Publication number: 20120251631
    Abstract: Provided is a method for treating or preventing peritonitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents. Further provided is a method for preventing peritoneal hemorrhage, adhesions and abscesses.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 4, 2012
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventors: Hojabr ALIMI, Andres Gutierrez
  • Patent number: 8273382
    Abstract: A composition for anti-microbial effect in a water system such as a pulp and paper processing line with an aqueous slurry. The composition comprises a free chlorine-generating biocide comprising a chlorine source, urea, and an alkali in a concentration sufficient to provide a pH greater than 10, and typically at least pH 11.
    Type: Grant
    Filed: January 19, 2010
    Date of Patent: September 25, 2012
    Assignee: Nalco Company
    Inventors: Laura E. Rice, Andrew J. Cooper, Robert L. Wetegrove, Michael V. Enzien
  • Publication number: 20120231091
    Abstract: Provided is an efficient method of inducing differentiation of a pulp cell into an odontoblast. Also provided is an agent for inducing differentiation capable of inducing differentiation into an odontoblast efficiently. The method of inducing differentiation of a pulp cell into an odontoblast includes using a substance capable of activating a Wnt signaling pathway. Further, the agent for inducing differentiation includes a substance capable of activating a Wnt signaling pathway. Specifically, the substance capable of activating a Wnt signaling pathway is any one selected from sodium perchlorate, sodium perchlorate, lithium chloride, Norrin, and R-Spondin2.
    Type: Application
    Filed: November 16, 2010
    Publication date: September 13, 2012
    Applicant: National University Corporation Okayama University
    Inventors: Takashi Yamashiro, Hiroshi Kurosaka, Noriaki Kawanabe
  • Patent number: 8257748
    Abstract: Described are compositions containing a mixture of (a) particulate calcium hypochlorite and (b) an amount of aluminum hydroxide that is sufficient to increase the UN-burn time of the composition by a factor of at least 2.5 compared to that of the calcium hypochlorite, the composition having an available chlorine content of at least 35 weight percent. Further described are solid compositions of (a) granular calcium hypochlorite having a UN Packing Group oxidizer classification of II, and (b) an amount of aluminum hydroxide such that the composition is classified as a Packing Group III Division 5.1 oxidizer or as a non-Division 5.1 oxidizer, the composition having an available chlorine content of at least 40 weight percent. Further described are formed articles prepared from the above-described compositions.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: September 4, 2012
    Assignee: PPG Industries Ohio, Inc.
    Inventors: Stanley R. Pickens, Robert B. Simmons